Category: prescription drugs

Warren Is Right. Presidents Have The Power To Bypass Congress On Drug Pricing.

But like all of health care, it’s complicated.

5 Things To Know About Trump’s Medicaid Block Grant Plan

Federal officials unveiled guidance for states that want to opt out of some of the current funding program and instead seek a fixed payment to gain more flexibility.

A Guide To Following The Health Debate In The 2020 Elections

As the Democratic primary campaign nears pivotal voting, important aspects of health care policy are being overlooked.

KFF Health Tracking Poll – January 2020: Medicare-for-all, Public Option, Health Care Legislation And Court Actions

This month’s KFF Health Tracking poll examines public opinion and knowledge of Medicare-for-all and a public option, President Trump’s approval on health care programs and issues, the public’s priorities for Congress, and public opinion on the Affordab…

Call For FDA To Withdraw Preterm Birth Drug Divides Doctors and Insurers

A study ordered by the Food and Drug Administration failed to prove that Makena, the only drug approved to prevent premature birth, is effective. While a panel of experts has recommended withdrawing the drug’s approval, many doctors are wary.

Team Trump Says Administration’s Action On Health Care ‘Is Working.’ Is It?

The impact of the Trump administration’s health policies is not as clear-cut as the president’s reelection campaign suggests.

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.

KHN’s ‘What The Health?’: ACA Still Under A Cloud After Court Ruling

A federal appeals court in New Orleans has agreed with a lower court that a key piece of the Affordable Care Act is unconstitutional. But it is sending the case back to the lower-court judge to decide how much of the rest of the law can stand. Also, Congress is leaving town after finishing work on a major spending bill that includes many changes to health policy. Margot Sanger-Katz of The New York Times, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more.

Border Fight: Trump’s Plan To Import Cheaper Drugs From Canada Faces Hurdles

The administration’s proposed rule to allow states to bring in prescription medications isn’t expected to provide immediate relief.

Quick Look: Antiretroviral Price Increases in Medicare Part D

Drug price concerns in the U.S., including for antiretrovirals, the mainstay of HIV treatment and, increasingly prevention, have prompted the introduction of several policy proposals. One proposal would require manufacturers to provide a rebate to the …